Skip to main content
. 2019 Jun 28;17(5):723–732. doi: 10.1007/s40258-019-00491-6

Table 3.

Cost base input values, ranges, and standard deviations used for sensitivity analyses

Age group (years) Base value Range Standard deviation References
Cost per HZ case, $
 50–59 264 211.20, 316.80 26.94 Friesen et al. [12]; Ontario calculationsa
 60–64 264 211.20, 316.80 26.94
 65–69 301 240.80, 361.20 30.71
 70–79 301 240.80, 361.20 30.71
 ≥ 80 301 240.80, 361.20 30.71
Cost per PHN case, $
 50–59 921 571.02, 1270.98 178.56 Friesen et al. [12]; Ontario calculationsa
 60–64 921 571.02, 1270.98 178.56
 65–69 1639 571.02, 1270.98 317.77
 70–79 1639 571.02, 1270.98 317.77
 ≥ 80 1639 1016.18, 2261.82 317.77
Vaccine cost, RZV, $
 All age groups 122 115.90, 128.10 IMS
Vaccine cost, ZVL, $
 All age groups 176.77 IMS
Vaccine administration, $
 First dose 4.50 4.50, 9.60 Ontario calculationsa
 Second dose 9.60 4.50, 9.60
Costs due to AEs per vaccinated individual, RZV, $
 50‒59 2.88 1.44, 4.32 0.734 Ontario calculationsa
 60‒64 2.62 1.31, 3.93 0.668
 65‒69 2.89 1.45, 4.34 0.737
 70‒79 2.81 1.41, 4.22 0.716
 ≥ 80 2.81 1.41, 4.22 0.716
Costs due to AEs per vaccinated individual, ZVL, $
 50‒59 1.70 0.85, 2.55 0.433 Ontario calculationa
 60‒64 1.70 0.85, 2.55 0.433
 65‒69 1.70 0.85, 2.55 0.433
 70‒79 1.70 0.85, 2.55 0.433
 ≥ 80 1.70 0.85, 2.55 0.433

All $ refer to Canadian dollars

AE adverse event, HZ herpes zoster, PHN postherpetic neuralgia, RZV adjuvanted recombinant zoster vaccine, ZVL zoster vaccine live

aDerived from Ontario Ministry of Health and Long-term Care (MOHLTC) fee schedules and Ontario Case Costing Initiative (OCCI)